EXPLORING 5G TECHNOLOGY: OPPORTUNITIES AND CHALLENGES IN TELECOMMUNICATIONS
International Journal of Information and Communication Technology Trends · 31.12.2023 · 3 (1) · 10-20
DOI: 10.71465/ijictt32 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Information and Communication Technology Trends, online erschienen am 31.12.2023. Verfasst von Dr. Ayesha Qureshi. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
5G technology represents the next leap in telecommunications, promising to revolutionize connectivity with faster speeds, lower latency, and greater capacity. This paper explores the opportunities and challenges associated with the deployment of 5G networks in Pakistan. By examining the technological advancements, socio-economic implications, and regulatory frameworks, this study aims to provide a comprehensive understanding of 5G's potential in enhancing telecommunications. Additionally, it highlights the challenges faced by Pakistan in achieving widespread 5G adoption, including infrastructural, financial, and regulatory barriers. The findings underscore the need for strategic planning, public-private partnerships, and investment in both infrastructure and research to leverage the full potential of 5G technology.
Zitieren
APA
Qureshi, D. A. (2023). EXPLORING 5G TECHNOLOGY: OPPORTUNITIES AND CHALLENGES IN TELECOMMUNICATIONS. International Journal of Information and Communication Technology Trends, 3(1), 10-20. https://doi.org/10.71465/ijictt32
Vancouver
Qureshi DA. EXPLORING 5G TECHNOLOGY: OPPORTUNITIES AND CHALLENGES IN TELECOMMUNICATIONS. International Journal of Information and Communication Technology Trends. 2023;3(1):10-20. doi:10.71465/ijictt32
BibTeX
@article{Qureshi2023,
author = {Qureshi, Dr. Ayesha},
title = {EXPLORING 5G TECHNOLOGY: OPPORTUNITIES AND CHALLENGES IN TELECOMMUNICATIONS},
journal = {International Journal of Information and Communication Technology Trends},
year = {2023},
volume = {3},
number = {1},
pages = {10--20},
doi = {10.71465/ijictt32}
}
EUVIMED